Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease

Respirology

Volumn 18, Issue 7, 2013, Pages 1069-1075

  Arja, Cholendra ^a   Surapaneni, Krishna Mohan ^b   Raya, Premanand ^c   Adimoolam, Chandrasekar ^d   Balisetty, Badhareenadhudu ^a   Kanala, Kodanda Reddy ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

^c Premananda Allergy and Chest Hospital   (India)

^d Southern Regional Centre   (India)

Author keywords

antioxidant; chronic obstructive pulmonary disease; oxidant; smoking; spirometry

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIPID PEROXIDATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; STAGING;

ANTIOXIDANT; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; OXIDANT; SMOKING; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SUPEROXIDE DISMUTASE;

EID: 84884855225     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12118     Document Type: Article

References (49)

1. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and metaanalysis. Eur. Respir. J. 2006; 28: 523-532.
2. Jindal SK, Aggarwal AN, Gupta D,. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking. Indian J. Chest Dis. Allied Sci. 2001; 43: 139-147.
3. Fowles J, Dybing E,. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003; 12: 424-430.
4. MacNee W,. Oxidants/antioxidants and COPD. Chest 2000; 117: 303S-317.
5. de Torres JP, Marín JM, Casanova C, et al. Lung cancer in patients with chronic obstructive pulmonary disease, incidence and predicting factors. Am. J. Respir. Crit. Care Med. 2011; 184: 913-919.
6. Repine JE, Bast A, Lankhorst I, et al. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997; 156: 341-357.
7. Andersen HR, Nielsen JB, Nielsen F, et al. Antioxidative enzyme activities in human erythrocytes. Clin. Chem. 1997; 43: 562-568.
8. Rahman I, Swarska E, Henry M, et al. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55: 189-193.
9. Rahman I, MacNee W,. Role of oxidants/antioxidants in smoking induced lung diseases. Free Radic. Biol. Med. 1996; 21: 669-681.
10. Rahman I, MacNee W,. Lung glutathione and oxidative stress: implications in cigarette smokeinduced airway disease. Am. J. Physiol. 1999; 277: L1067-1088.
11. Kinnula VL,. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005; 60: 693-700.
12. Kluchová Z, Petrásová D, Joppa P, et al. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol. Res. 2007; 56: 51-56.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD. Executive summary. National Institutes of Health. 2006. [Accessed 22 November 2012.] Available from URL: http://www.who.int/respiratory/copd/GOLD-WR-06.pdf
14. World Health Organization. 10 facts on obesity '. 2000. [Accessed 22 November 2012.] Available from URL: http://www.who.int/features/factfiles/ obesity/facts/en/
15. Kumar R, Prakash S, Kushwah AS, et al. Breath carbon monoxide concentration in cigarette and bidi smokers in India. Indian J. Chest Dis. Allied Sci. 2010; 52: 19-24.
16. Dodge JF, Mitchell G, Hanahan DJ,. The preparation and chemical characterization of hemoglobin free ghosts of human red blood cells. Arch Biochem. Biophys. 1968; 100: 119-130.
17. Quist EH,. Regulation of erythrocyte membrane shape by calcium ion. Biochem. Biophys. Res. Commun. 1980; 92: 631-637.
18. Satoh K,. Serum lipid peroxide in cerebrovascular disorder determined by new colorimetric method. Clin. Chim. Acta 1978; 90: 37-43.
19. Misra HP, Fridovich I,. The role of superoxide anion in the auto oxidation of epinephrine and a simple assay for super oxide dismutase. J. Biol. Chem. 1972; 247: 3170-3175.
20. Beers RF, Sizer IW,. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952; 195: 133-140.
21. Paglia DE, Valentine WN,. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967; 70: 158-159.
22. Warholm M, Guthenberg C, von Bahr C, et al. Glutathione transferases from human liver. In:, Alton M, (ed.) Methods of Enzymology. Vol. 113. Academic Press, Waltham, MA, 1985; 500-501.
23. Beutler E, Duron O, Kelly BM,. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963; 61: 882-888.
24. Tuncer T, Fikret K, Selim MT, et al. Comparison of serum malondialdehyde levels determined by two different methods in patients with COPD: HPLC or TBARS methods. Lab. Med. 2005; 36: 41-44.
25. Corradi M, Rubinstein I, Andreoli R, et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 1380-1386.
26. Joppa P, Petrásová D, Stancák B, et al. Oxidative stress in patients with COPD and pulmonary hypertension. Wien. Klin. Wochenschr. 2007; 119: 428-434.
27. Vibhuti A, Arif E, Mishra A, et al. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD. Clin. Chim. Acta 2010; 411: 474-480.
28. Boots AW, Haenen GR, Bast A,. Oxidant metabolism in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2003; 46: 14s-27s.
29. Montaño M, Cisneros J, Ramírez-Venegas A, et al. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking. Inhal. Toxicol. 2010; 22: 868-874.
30. Calikoǧlu M, Unlü A, Tamer L, et al. The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin. Chem. Lab. Med. 2002; 40: 1028-1031.
31. William M, Rahman I,. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: S58-S65.
32. van der Toorn M, Smit-de Vries MP, Slebos DJ, et al. Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 293: L1156-1162.
33. Möller W, Heimbeck I, Weber N, et al. Fractionated exhaled breath condensate collection shows high hydrogen peroxide release in the airways. J. Aerosol. Med. Pulm. Drug Deliv. 2010; 23: 129-135.
34. Gaetani GF, Galiano S, Canepa L, et al. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989; 73: 334-339.
35. Orhan H, Evelo CT, Sahin G,. Erythrocyte antioxidant defense response against cigarette smoking in humans-the glutathiones-transferase vulnerability. J. Biochem. Mol. Toxicol. 2005; 19: 226-233.
36. Yildiz L, Kayaoǧlu N, Aksoy H,. The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin. Chem. Lab. Med. 2002; 40: 612-615.
37. Tavilani H, Nadi E, Karimi J, et al. Oxidative stress in COPD patients, smokers and nonsmokers subjects. Respir. Care 2012; 57: 2090-2094.
38. Ruzena JT, Darina P, Zuzana K, et al. Lipid peroxidation and glutathione peroxidase activity in patients with copd: relationship to disease severity. Chest 2005; 128: 131S-a-131S.
39. Biljak VR, Rumora L, Cepelak I, et al. Glutathione cycle in stable chronic obstructive pulmonary disease. Cell Biochem. Funct. 2010; 28: 448-453.
40. Jones DP, Brown LA, Sternberg P,. Variability in glutathione-dependent detoxication in vivo and its relevance to detoxication of chemical mixtures. Toxicology 1995; 105: 267-274.
41. Levine PH, Hardin JC, Scoon KL, et al. Effect of corticosteroids on the production of superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes. Inflammation 1981; 5: 19-27.
42. Mak JC, Ho SP, Yu WC, et al. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur. Respir. J. 2007; 30: 684-690.
43. Matskevich GN, Korotkina RN, Devlikanova ASh, et al. The study of the antioxidant enzymes in erythrocytes in lung diseases. Patol. Fiziol. Eksp. Ter. 2003; 2: 23-25.
44. Scott MD, Eaton JW, Kuypers FA, et al. Enhancement of erythrocyte superoxide dismutase activity: effects on cellular oxidant defense. Blood 1989; 74: 2542-2549.
45. Imboden M, Downs SH, Senn O, et al. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir. Res. 2007; 8: 2.
46. Mehrotra S, Sharma A, Kumar S, et al. Polymorphism of glutathione S-transferase M1 and T1 gene loci in COPD. Int. J. Immunogenet. 2010; 37: 263-267.
47. Liu CS, Wei YH,. Age-associated alteration of blood thiol-group-related antioxidants in smokers. Environ. Res. 1999; 80: 18-24.
48. Lakhdar R, Denden S, Mouhamed MH, et al. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease. Exp. Lung Res. 2011; 37: 195-204.
49. Donohue JF,. Ageing, smoking and oxidative stress. Thorax 2006; 61: 461-462.